Zdrowie i gospodarka · 09/05/2025

FDA Classifies Device for Detecting Microbial Nucleic Acids by FISH in Clinical Specimens into Class II with Special Controls

The FDA is classifying a device to detect and identify microbial nucleic acids by fluorescence in situ hybridization in clinical specimens into Class II with special controls, aiming to enhance patient access to innovative devices while ensuring safety and effectiveness.